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SCIENTIFIC OPINION 
Scientific Opinion on the ‘Biomation’ application for an alternative method 
for the treatment of animal-by-products
1
 
EFSA Panel on Biological Hazards (BIOHAZ)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
A method alternative to the ones already approved in the current legislation, called „Biomation‟ process, for the 
treatment of Category (Cat.) 2 and 3 Animal By-Products (ABP)
4
 was assessed. The process consists of an 
alkaline treatment. The target parameters are: particle size ≤ 5mm, temperature 70 °C, pH 12.5, exposure time 
20 minutes. According to the application received also Cat. 1 ABP can enter the processing plant and it has then 
to be removed from the rest of the ABP material and treated according to current legislation. The end product 
generated by the „Biomation‟ process is intended to be used as an organic fertiliser and soil improver. According 
to the legislation in force, before being used as an organic fertiliser, Cat. 2 (and mixes of Cat. 2 and 3) material 
should be treated with a sterilisation process (i.e. 133 °C / 20 min / 3 bars / 50 mm particle size)
5
. The hazard 
identification provided by the applicant was not adequately addressed, since the most resistant organisms 
(including TSE agents) were not properly identified, and an experimental validation with representative test-
organisms under practical conditions was not performed. A laboratory experiment was performed but its results 
were not clear and did not allow a proper assessment of the level of risk reduction of the relevant biological 
hazards achieved by the process. Moreover, it was noticed that it is not certain that the values of the parameters 
used in the laboratory experiment would be homogenously reached in all the material under real scale 
conditions. Major deficiencies were noticed in the HACCP plan provided. It was concluded that there is no 
evidence that the proposed alternative method is equivalent to the sterilization process defined in the current 
legislation. 
© European Food Safety Authority, 2012 
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SUMMARY 
Following a request from the UK Competent Authority, the Panel on Biological Hazards (BIOHAZ) 
was asked to deliver a scientific opinion on the „Biomation‟ application for an alternative method for 
the treatment of animal-by-products. 
The application received concerns a new method for the treatment of Category (Cat.) 2 and 3 Animal 
By-Products (ABP) as defined in Reg. 1069/2009
6
 (the ABP Regulation). 
According to the applicant, fallen stock containing Specified Risk Material (SRM), which is included 
in the list of Cat. 1 ABP in article 8 of the ABP Regulation, can also enter the processing plant. In this 
case the fallen animals are received in a separate area and the SRM is removed using the same 
methods employed in slaughtering plants. The removed SRM is then handled according to the 
requirements foreseen in the ABP Regulation and on its implementing measures laid down in Reg. 
142/2011
7
 and incinerated in an approved incineration plant. 
The proposed process consists of 6 steps i) mincing the material to a particle size ≤ 5mm; ii) transfer 
to a refrigerated holding tank; iii) treatment by alkaline hydrolysis by addition of NaOH to a 
concentration of at least 15% to the material until reaching a pH of at least 12.5 and keeping it at a 
temperature of 70 °C for 20 minutes; iv) treatment by neutralization by addition of acrylic acid at a 
temperature of 70 °C and an exposure time of 20 - 30 minutes in order to decrease the pH from 12.5 - 
13.2 to 7.0  - 7.7; v) treatment by polymerization by addition of ammonium persulfate 0.5% (w/w) at a 
temperature of 70 °C and an exposure time of 10 minutes; vi) drying in a drying tunnel at 200 °C - 
220 °C. 
The end product generated by the process is intended to be used as an organic fertiliser and soil 
improver. 
Following article 13 (d) of the ABP Regulation, in order to be used as organic fertiliser and soil 
improver, Cat. 2 (and mixes of Cat. 2 and 3) material should be treated according to method 1 as 
defined in Annex IV to Regulation (EU) 142/2011 (i.e. 133 °C / 20 min / 3 bars / 50 mm particle 
size). 
The parameters reported by the applicant as critical for the risk reduction were: particle size ≤ 5mm, 
temperature 70 °C, pH 12.5, exposure time 20 minutes. 
The applicant listed several viral and bacterial pathogens and diseases that regarded as relevant in this 
context. Since Cat. 1 material is handled at the same plant, cross contamination of the ABP to be 
treated with TSE agents cannot be excluded. Due to the variety of material intended to be used in the 
proposed process and on the uncertainty on the cause of the death of the possible fallen animals 
entering the process, the presence of highly thermo- and chemo resistant hazards cannot be considered 
negligible. The possibility of the presence of such hazards was not adequately addressed in the 
application and the biological agent/s which are the most difficult to be inactivated by the critical 
parameters and which should be retained as the primary target/s for demonstrating the risk reduction 
achieved by the process were not adequately identified. Moreover, it cannot be excluded that the 
subsequent polymerisation in this process could possibly lead to the stabilisation of any residual TSE 
infectivity. 
                                                     
6  Regulation (EC) No 1069/2009 of the European Parliament and of the Council of 21 October 2009 laying down health 
rules as regards animal by-products and derived products not intended for human consumption and repealing Regulation 
(EC) No 1774/2002 (Animal by-products Regulation) (OJ L 300, 14.11.2009). 
7  Commission Regulation (EU) No 142/2011 of 25 February 2011 implementing Regulation (EC) No 1069/2009 of the 
European Parliament and of the Council laying down health rules as regards animal by-products and derived products not 
intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items 
exempt from veterinary checks at the border under that Directive (OJ L 54, 26.2.2011). 
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No experimental validation of the process in technical or semitechnical scale in order to demonstrate 
its efficacy in field conditions was performed. The applicant‟s argumentation on the risk reduction 
provided by the process was primarily based on data from literature. The only experimental data 
provided by the applicant were related to a laboratory scale experiment with spores of Clostridium 
sporogenes that were selected as the target to demonstrate the risk reduction achieved by the process. 
No information was given on the reason why such spores were selected. The methods used in the 
experiment are not described in detail, the raw data are missing and the results, as described, are not 
clear and partly improbable. 
The applicant provided a HACCP plan that took into account the parameters considered as critical for 
the process. However, there was no indication on how and were such critical parameters could be 
monitored and implemented under real scale conditions. It was noticed that the plan provided does not 
contain clear provisions for the cleaning and disinfection of the means utilised during the process and 
for ensuring an adequate separation of dirty and clean areas. 
The risk associated with interdependent processes was considered by the applicant.  
The BIOHAZ Panel concluded that the hazard identification was not adequately addressed, since the 
most resistant organisms (including TSE agents) were not properly identified, and that no 
experimental validation with representative test-organisms under practical conditions was done. 
Moreover, it is not certain that the values of the parameters used in the laboratory experiment would 
be homogenously reached in all the material under real scale conditions. The results of the laboratory 
experiments performed are not clear and do not allow a proper assessment of the level of risk 
reduction of the relevant biological hazards achieved by the process.  
Major deficiencies were noticed in the HACCP plan provided.  
The Panel further concluded that there is no evidence that the proposed alternative method is 
equivalent to processing method 1 described under Regulation (EU) 142/2011, in terms of log10 
reduction of the relevant hazards, including TSE agents. 
To assess alternative methods, the Panel recommended that the relevant hazards and their level of 
inactivation to be targeted by the processing methods for Cat. 2 animal by-products should be 
specified in a more precise and detailed way. Moreover, to facilitate the assessment of the alternative 
methods for the treatment and the specific use of the Cat. 2 material under consideration it was 
recommended that i) test organisms with defined resistance patterns should be specified; and ii) the 
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BACKGROUND AS PROVIDED BY THE UK COMPETENT AUTHORITY 
An alternative method has been developed by a UK company (Incinerator Replacement Technology 
Ltd) for the processing of category 2 & category 3 animal by-products (ABPs). In the first stage of this 
method, which is called the „Biomation‟ process, an alkaline mix is introduced to the ABPs (after the 
ABPs have been reduced in particle size to a maximum of 5 mm) until a temperature of 70˚C is 
reached by exothermic reaction and heat. This temperature is then maintained for a period of 20 
minutes by means of a jacket heater. The minimum pH achieved by the addition of the alkaline mix is 
12.5. At this point it is claimed that the derived product has met a 6 log reduction for Clostridium 
sporogenes spores. In the second stage of the manufacturing process acrylic acid is added to the 
derived product to achieve neutral pH while the temperature continues to be maintained to 70˚C for 20 
minutes. Due to the slow addition of acrylic acid the pH of the product is decreasing from 12.5-13.2 to 
7.7. In the third and final stage of the manufacturing process ammonium persulfate 0.5% by weight 
(w/w) is added and mixed with the product to achieve polymerization whilst the temperature is 
maintained to 70˚C and the pH to 7.7 for 10 minutes. The final derived product of this process is 
intended to be used as an organic fertiliser/soil improver. 
TERMS OF REFERENCE AS PROVIDED BY THE UK COMPETENT AUTHORITY  
The UK competent authority asked EFSA to assess the proposed alternative method for the treatment 
of category 2 and 3 animal by-products in order to produce an organic fertiliser and whether the final 
derived product has reached an „end point‟ in the manufacturing chain.  
Clarification of the Terms of Reference 
The assessment was performed taking into account the criteria laid down in Art. 20, point 5 of Reg. 
1069/2009. The requestor asked also to assess if the final derived product can be considered as 
reaching an “end point” in the manufacturing chain. This is not under EFSA‟s remit in this context.  
„Biomation‟ application 
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ASSESSMENT 
1. Introduction 
The terminology used in this assessment conforms to the “Statement on technical assistance on the 
format for applications for new alternative methods for animal by-products” (EFSA Panel on 
Biological Hazards (BIOHAZ), 2010). The assessment only considered biological hazards. Other 
hazards that can occur due to the use or release of chemical substances are not considered.  
The assessment of the application received was performed taking into account the criteria laid down in 
Art. 20, point 5 of Regulation (EC) 1069/2009
8
 (the ABP Regulation). 
2. Full description of the process 
The application received concerns a new method for the treatment of Category (Cat.) 2 and 3 Animal 
By-Products (ABP) as defined in Reg. 1069/2009. The end product generated by the process is 
intended to be used as an organic fertiliser and soil improver. 
Following article 13 (d) of the ABP Regulation, in order to be used as organic fertiliser and soil 
improver, Cat. 2 (and mixes of Cat. 2 and 3) material should be treated according to method 1 as 
defined in Annex IV to Regulation (EU) 142/2011
9
 (i.e. 133 °C / 20 min / 3 bars / 50 mm particle 
size). 
According to the applicant, fallen stock containing Specified Risk Material (SRM), which is included 
in the list of Cat. 1 ABP in article 8 of the ABP Regulation, can also enter the processing plant. In this 
case the fallen animals are received in a separate area and the SRM is removed using the same 
methods employed in slaughtering plants. The removed SRM is then handled according to the 
requirements foreseen in the ABP Regulation and on its implementing measures laid down in Reg. 
142/2011 and incinerated in an approved incineration plant.  
The applicant reports that former foodstuffs (i.e. foodstuffs which are not longer intended for human 
consumption) are separated from any packaging prior to processing. However, it is not clear how this 
operation is performed. 
The main  equipments where the material is processed in are a macerator for mincing the Cat, 2 and 
Cat. 3 materials, an intermediate storage tank, a hermetically sealed pressure mixing vessel in which 
the three steps of the „Biomation‟ process are subsequently run and a drying tunnel for evaporating the 
water.  
The whole treatment process is characterized by the following main steps and parameters: 
1. Mincing of the material to a particle size ≤ 5mm.  
2. Transfer of the material to a refrigerated holding tank (no temperature data are given). 
3. Treatment by alkaline hydrolysis by addition of  at least 15% NaOH to the material until reaching 
a pH of at least 12.5 and keeping it at a temperature of 70 °C for 20 minutes. 
                                                     
8  Regulation (EC) No 1069/2009 of the European Parliament and of the Council of 21 October 2009 laying down health 
rules as regards animal by-products and derived products not intended for human consumption and repealing Regulation 
(EC) No 1774/2002 (Animal by-products Regulation) (OJ L 300, 14.11.2009). 
9  Commission Regulation (EU) No 142/2011 of 25 February 2011 implementing Regulation (EC) No 1069/2009 of the 
European Parliament and of the Council laying down health rules as regards animal by-products and derived products not 
intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items 
exempt from veterinary checks at the border under that Directive (OJ L 54, 26.2.2011). 
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4. Treatment by neutralization  by addition of acrylic acid at a temperature of 70 °C  and an exposure 
time of 20 – 3010 min in order to decrease the pH from 12.5 – 13.2 to 7.0  - 7.710. 
5. Treatment by polymerization by addition of ammonium persulfate 0.5% (w/w) at a temperature of 
70 °C and an exposure time of 10 min. 
6. Drying in a drying tunnel at 200 °C - 220 °C. 
It is intended that every batch of end product will be sampled (5 samples per batch) and sent to an 
approved laboratory to be analysed. The applicant reports that a batch of Cat. 2 material has to be 
tested for Cl. perfringens while a batch of Cat. 3 material has to be tested for Salmonella spp. and 
Enterobacteriaceae. In case a batch fails the laboratory analysis it has to be sent to disposal. However, 
the applicant did not provide any critical limit for the laboratory analysis to be performed. 
According to the applicant the critical steps for the risk reduction are the mincing of the material and 
the alkaline addition. The alkaline addition is performed in batches. 
The parameters reported by the applicant as critical for the risk reduction are: 
 particle size ≤ 5mm; 
 temperature 70 °C; 
 pH 12.5; 
 exposure time 20 minutes. 
No information is given on the transfer and storage of the minced material into the refrigerated tank 
and on the transfer of that material from the refrigerated tank to the mixing vessel. 
According to the description received steps 3, 4 and 5 take place into the same mixing vessel. 
During the process the exhaust air is passed through a filter to remove chemical gases. No clear 
information is given on the gases generated by the process (the applicant reports that these are mainly 
water vapours and ammonia) neither on the measure of the effect of such filter in reducing the quantity 
of gases and biological hazards which may be released into the environment.  
The waste water resulting from the cleaning of the equipment is collected in tanks and then disposed 
of according to current legislation. The fate of the water generated during the drying process is not 
described. 
A flow diagram of the proposed process under commercial conditions is shown in Figure 1. 
                                                     
10
 Divergent data are given in the application. 
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Figure 1:  Extract from the applicant‟s report: Flow diagram of the proposed process 
3. Full description of the material to be treated 
All type of Cat. 2 and Cat. 3 ABP can enter the processing plant. Since it is intended to process also 
fallen stock containing Specified Risk Material (SRM), Cat. 1 ABP, will also be handled on the same 
plant, while the SRM is removed for incineration in an approved incineration plant in a separate area 
and the remaining material subsequently transferred to the treatment process as Cat. 2 ABP.  
4. Hazard identification 
The material to be treated is represented by fallen animals of different species and all other kinds of 
ABP including former foodstuffs. The hazards concerned are pathogenic microorganisms and 
infectious agents that can be present in fallen animals and other ABP. They can be both zoonotic 
„Biomation‟ application 
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agents and animal pathogens. They include bacteria, fungi, viruses and parasites. Food waste spoilage 
organisms and other contaminants as well as toxins must be taken into account too. The applicant 
listed several viral and bacterial pathogens and diseases (Rabies virus, Influenza virus, Salmonella 
spp., Campylobacter spp., coliforms, Enterobacteriaceae, E. coli O157, Erysipetothrix rhusiopathiae, 
Listeria monocytogenes, tuberculosis, brucellosis, anthrax, Cl. botulinum, Cl. perfringens, trichinella, 
toxoplasma, taeniasis, swine fever virus, parvovirus, foot and mouth disease virus, Staphylococcus 
aureus, Mycoplasma spp., viruses and Clostridia spp.) that were regarded as relevant in this context. 
Since Cat. 1 material is handled at the same plant, cross contamination of the ABP to be treated with 
TSE agents cannot be excluded.  
However, due to the variety of material intended to be used in the proposed process and on the 
uncertainty on the cause of the death of the possible fallen animals entering the process, the presence 
of highly thermo- and chemo resistant hazards cannot be considered negligible. In particular method 1 
as defined in the current legislation, is able to minimise the risks due to unidentified agents, such as 
bacterial spores, thermo resistant viruses and in particular TSE agents. The possibility of the presence 
of such hazards was not adequately addressed in the application and the biological agent/s which are 
the most difficult to be inactivated by the critical parameters and which should be retained as the 
primary target/s for demonstrating the risk reduction achieved by the process were not adequately 
identified. Moreover, it cannot be excluded that the subsequent polymerisation in this process could 
possibly lead to the stabilisation of any residual TSE infectivity.  
5. Level of risk reduction 
The applicant refers to the first treatment step of alkaline hydrolysis as the only part of the process 
relevant for risk reduction but no experimental validation of this step in technical or semitechnical 
scale was performed in order to demonstrate its efficacy in field conditions. The applicant‟s 
argumentation concerning risk reduction, including TSE agents, due to the process applied is primarily 
based on data from literature (e.g. Appendix 1 and 11 to the application dossier).  The only 
experimental data given in the application has been elaborated in two different sets of laboratory scale 
experiments performed by the applicant and by an external laboratory with different spore 
preparations of Clostridium sporogenes and minced meat. Those experiments seem to have more the 
character of range finding experiments, than of a pre-validation study. No reasons were given, why 
Clostridium sporogenes spores were identified by the applicant as the target to demonstrate the risk 
reduction achieved by the process. 
Since these are the only experimental data presented in the context of the application, some 
methodological details will be given below.  
In the experimental study carried out by the applicant, the spore suspension used was prepared by the 
laboratory of the applicant itself. 1200 g of minced meat (5 mm particle size) for petfood was 
inoculated and mixed with a Cl. sporogenes spore suspension to reach a concentration of 6.3 – 6.8 
log10 spores per gram of meat.  
The total amount of inoculated material was then divided in 12 beakers with 100g of material in each 
of them.  
In order to assess the risk reduction reached by the proposed process the applicant measured the 
reduction of the number of viable spores at different points in time in two sets of experiments, 
respectively at 60 °C and 70 °C, with sodium hydroxide concentrations of 0, 5, 10, 15, 20 and 25% 
(w/w). The applicant reported that the temperature never dropped below 60 and 70 °C in the two set of 
experiments. 
The reduction of the number of viable spores achieved in the two sets of experiments as reported by 
the applicant is listed in table 1 and 2. 
„Biomation‟ application 
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Table 1:  Log CFU/g of Cl. sporogens spores at 60 °C in various sodium hydroxide concentrations 
within 20 minutes (Mean value=5±Standard Deviation) [sic].  
 
 
Table 2:  Log CFU/g of Cl. sporogens spores at 70 °C in various sodium hydroxide concentrations 
within 20 minutes (Mean value=5±Standard Deviation) [sic]. 
 
The presentation of the data is confusing (e.g. it is doubtful that the standard deviation of the control is 
in the same range as the mean bacterial count). The methods used in the experiment are not described 
in detail, the raw data are missing and the results, as described, are not clear and partly improbable. 
For example, according to the applicant 5% NaOH can lead to 3 log10 reduction of Cl. sporogenes 
spores within 20 minutes at 60 and 70 °C. However, the results from table 1 and 2 do not support this 
conclusion. Moreover, according to the applicant any concentration of NaOH above 15% (pH of at 
least 12.5) at 70 °C for 20 minutes leads to the total destruction of spores (> 6log10 reduction). 
However, given that as reported by the applicant the detection limit for the method for counting the Cl. 
sporogens spores is 10 CFU/ml, the 6 log10 reduction is not really measured. 
The exact temperature at which the experimental validation was performed was not provided in the 
applicant´s report and could also have been higher than the critical temperature proposed for the 
process under real scale conditions. 
„Biomation‟ application 
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Moreover, the measure of one of the critical parameters according to the applicant (pH) was not 
presented for the laboratory trial. In this trial only the concentration of NaOH is reported. The 
applicant associated 15% concentration of NaOH with a pH of 12.5 without providing any supporting 
data.  
According to the applicant these experiments were then validated by an external laboratory (as 
reported in Appendix 10 to the application dossier). In those experiments 0.1 ml of a  spore suspension 
(5x10
7
 CFU//ml) prepared out of a freeze dried preparation were added to 10 g of minced meat (5x10
5
 
spores per gram of meat ) and heated in the water bath for 10 minutes. 1g of this mixture was 
transferred into 9ml of saline solution and NaOH was added to reach final concentrations between 5% 
and 25%. Samples heated at 70 °C were taken after 5 min to 20 min, immediately neutralized with 
HCl, heat shocked and the CFU of surviving spores were determined. According to their experiments, 
treatments with NaOH at concentrations of 10%, 15%, 20% and 25%, completely  inactivate  all 
spores after an exposure time of  5 min.  
However, the description of the protocols and the results of the two experiments differs. This raises 
doubts about the experimental procedure really applied and the reliability of the results provided. 
None of the involved laboratories had characterized the resistance of the spore preparation used and 
validated the microbiological methods applied. Hence, it cannot be excluded that this fact was the 
reason for the high variations in the zero values (exposure time 0 min and 0% NaOH) in both studies. 
Concerning the microbiological safety of waste water from the process, the applicant also tested the 
sterility of the water extracted from the wet material during the drying process by placing 100g of the 
treated material in a round flask connected to a condenser. The flask was heated to dry the end 
product. The condensed water was collected and passed through a microbiological filter. The filter was 
placed on a nutrient agar plate and cultivated at 37 °C for 3 days. No colonies were detected.   
6. HACCP plan 
Although the applicant reports that “any batch (or process load) not meeting the critical parameters 
for the process will be sent for disposal” and the HACCP plan provided has listed the critical 
parameters in the description of the process, is not clear and there is no indication on how and where 
the critical parameters for the process (particle size, temperature, pH and exposure time) can be 
monitored and implemented under real scale conditions.  
The HACCP plan does not contain clear provisions for the cleaning and disinfection of the means 
utilised during the process and for ensuring an adequate separation of dirty and clean areas. 
7. Risk associated with interdependent processes 
The applicant considered different steps that could influence the level of risk reduction achieved by 
the process. 
The SRM removed is handled according to the requirements foreseen in the ABP Regulation and on 
its implementing measures laid down in Reg. 142/2011 and subsequently sent for incineration in an 
approved incineration plant.  
The exhaust air generated by the process is passed through a filter to remove chemical gases. 
However, no clear information is given on the gases generated by the process (the applicant reports 
that these are mainly water vapours and ammonia) neither on the measure of the effect of such filter in 
reducing the quantity of gases and biological hazards which may be released into the environment.  
The waste water resulting from the cleaning of the equipment is collected in tanks and then disposed 
of according to current legislation. 
The fate of the water generated during the drying process is not described. 
„Biomation‟ application 
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8. Risk associated with the intended end use of the product  
According to the applicant, since the end product is sterile, there is no risk for human and animal 
health and the environment. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
 The application concerns treatment of Animal By-Products of Category 2 and 3, as defined in the 
Regulation (CE) 1069/2009, for organic fertilisers. The standard processing method to be used for 
this purpose, called method 1, is specified under Regulation (EU) 142/2011. 
 The hazard identification was not adequately addressed since the most resistant organisms 
(including TSE agents) were not properly identified. 
 The process proposed by the applicant has not been properly validated experimentally under real 
scale conditions. Moreover, it is not certain that the values of the parameters used in the laboratory 
experiment would be homogenously reached in all the material under real scale conditions. 
 The results of the laboratory experiment performed are not clear and do not allow a proper 
assessment of the level of risk reduction of the relevant biological hazards achieved by the 
process. 
 Major deficiencies were noticed in the HACCP plan provided. 
 There is no evidence that the proposed alternative method is equivalent to processing method 1 
described under Regulation (EU) 142/2011, in terms of log10 reduction of the relevant hazards, 
including TSE agents. 
RECOMMENDATIONS 
 To assess alternative methods, the relevant hazards and their level of inactivation to be targeted by 
the processing methods for Cat. 2 animal by-products should be specified in a more precise and 
detailed way. 
 To facilitate the assessment of the alternative methods for the treatment and the specific use of the 
Cat. 2 material under consideration i) test organisms with defined resistance patterns should be 
specified; and ii) the required level of quantitative reduction of such organisms should also be 
provided. 
DOCUMENTATION PROVIDED TO EFSA 
1. „Biomation‟ application. November 2011. Submitted by the Animal Health and Veterinary 
Laboratories Agency, London, UK. 
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